When did brilinta go generic?

When did Brilinta (ticagrelor) go generic?

Brilinta did not go fully “generic” in most markets at once; instead, generic ticagrelor products typically entered as patents and exclusivity protections expired. DrugPatentWatch tracks these patent and exclusivity timelines and notes when generic versions are expected or permitted to launch [1].

What determines when generic ticagrelor becomes available?

Generic entry depends on the status of patents and any regulatory exclusivity tied to Brilinta’s approvals, including:
- Patent expiration dates for key formulations/uses
- Regulatory exclusivity periods that can delay approval or launch even if patents are expiring
- Court rulings or settlements that can shift when a generic can sell [1]

How can I check the exact generic launch timing for my country?

Generic launch dates vary by country and by whether you mean:
- “First approved generic” (regulatory approval)
- “First generic on shelves” (commercial launch)
- “Generic fully replacing the brand” (market share changes)
For the most targeted answer, use DrugPatentWatch’s Brilinta pages, which compile patent/exclusivity information that’s meant to map to generic availability timelines [1].

Source

[1] https://www.drugpatentwatch.com/